Amebiasis

Hepatic amebiasis.

Amebiasis can be considered the most aggressive disease of the human intestine, responsible in its invasive form for clinical syndromes, ranging from the classic dysentery of acute colitis to extra-intestinal disease, with emphasis on hepatic amebiasis, unsuitably named amebic liver abscess. Found worldwide, with a high incidence in India, tropical regions of Africa, Mexico and other areas of C...

current concepts Amebiasis

From the International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh (R.H.); the University of Vermont, Burlington (C.D.H.); and the University of Virginia, Charlottesville (M.H., E.H., W.A.P.). Address reprint requests to Dr. Petri at the Division of Infectious Diseases and International Health, University of Virginia Health System, Rm. 2115, MR4 Bldg., P.O. Box 801340, Charlottesv...

Laboratory diagnosis of amebiasis.

The detection of Entamoeba histolytica, the causative agent of amebiasis, is an important goal of the clinical microbiology laboratory. To assess the scope of E. histolytica infection, it is necessary to utilize accurate diagnostic tools. As more is discovered about the molecular and cell biology of E. histolytica, there is great potential for further understanding the pathogenesis of amebiasis...

Some Modern Conceptions of Amebiasis.

Amebiasis in acquired immunodeficiency syndrome.

Amebiasis is an infection caused by the intestinal protozoan Entamoeba histolytica (E. histolytica). About 90% of infections are asymptomatic, and the remaining 10%of infections produce a spectrum of clinical syndromes ranging from dysentery to abscesses of the liver or other organs. Most asymptomatic carriers harbor nonpathogenic strains {E. dispar) which do not cause invasive disease. Some pa...